Open Access
| Issue |
BIO Web Conf.
Volume 237, 2026
2026 8th International Conference on Biotechnology and Biomedicine (ICBB 2026)
|
|
|---|---|---|
| Article Number | 02024 | |
| Number of page(s) | 7 | |
| Section | Pharmacology, Natural Products and Drug Delivery | |
| DOI | https://doi.org/10.1051/bioconf/202623702024 | |
| Published online | 10 June 2026 | |
- Tafech A, Stéphanou A. On the Importance of Acidity in Cancer Cells and Therapy. Biology (Basel), 2024 Mar 29;13(4):225. [Google Scholar]
- Bogdanov A, Bogdanov A, Chubenko V, Volkov N, Moiseenko F, Moiseyenko V. Tumor acidity: From hallmark of cancer to target of treatment. Front Oncol, 2022 Aug 29;12:979154. [Google Scholar]
- Mahoney BP, Raghunand N, Baggett B, Gillies RJ. Tumor acidity, ion trapping and chemotherapeutics. I. Acid pH affects the distribution of chemotherapeutic agents in vitro. Biochem Pharmacol, 2003 Oct 1;66(7):1207–18. [Google Scholar]
- Andreucci E, Peppicelli S, Ruzzolini J, Bianchini F, Biagioni A, Papucci L, Magnelli L, Mazzanti B, Stecca B, Calorini L. The acidic tumor microenvironment drives a stem-like phenotype in melanoma cells. J Mol Med (Berl), 2020 Oct;98(10):1431–1446. [Google Scholar]
- Cappellesso F, Mazzone M, Virga F. Acid affairs in anti-tumour immunity. Cancer Cell Int, 2024 Oct 27;24(1):354. [Google Scholar]
- Zhuang Y, Tong L, Sun X. Acidic Tumour Microenvironments and Emerging Therapeutic Strategies for Cancer Therapy. Yonsei Med J, 2025, 66(10): 619–629. [Google Scholar]
- Zhang T Q, Lv Q Y, Jin W L. The cellular-centred view of the hypoxic tumour microenvironment: Molecular mechanisms and therapeutic interventions. Biochim Biophys Acta Rev Cancer, 2024, 1879(5): 189137. [Google Scholar]
- Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, Jain RK. Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev. 2011 Jul;91(3):1071–121. [Google Scholar]
- Lee PWT, Koseki LR, Haitani T, Harada H, Kobayashi M. Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells. Cancers (Basel). 2024 Apr 29;16(9):1729. [Google Scholar]
- Scanlon SE, Glazer PM. Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment. DNA Repair (Amst), 2015 Aug;32:180–189. [Google Scholar]
- Ozcan G. The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting. Front Cell Dev Biol, 2023 Feb 8;11:1082057. [Google Scholar]
- Shang T, Jia Z, Li J, Cao H, Xu H, Cong L, Ma D, Wang X, Liu J. Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance. J Hematol Oncol, 2025 Mar 18;18(1):32. [Google Scholar]
- Prakash J, Shaked Y. The Interplay between Extracellular Matrix Remodelling and Cancer Therapeutics. Cancer Discovery, 2024, 14(8): 1375–1388. [Google Scholar]
- Gong P, Wang F, Hua Y, Ying J, Chen J, Qiao Y. Collagenase-mediated extracellular matrix targeting for enhanced drug penetration and therapeutic efficacy in nanoscale delivery systems for cancer therapy. J Nanobiotechnology, 2025 Nov 24;23(1):733. [Google Scholar]
- Kariya Y, Nishita M. Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications. Int J Mol Sci, 2025 Mar 28;26(7):3143. [Google Scholar]
- Masuda H. Cancer-associated fibroblasts in cancer drug resistance and cancer progression: a review. Cell Death Discov, 2025, 11(1): 341. [Google Scholar]
- Liu Y, Liang J, Zhang Y, et al. Drug resistance and the tumour immune microenvironment: An overview of current understanding (Review). Int J Oncol, 2024, 65(4): 96. [Google Scholar]
- Wang L, Zhang L, Zhang Z, Wu P, Zhang Y, Chen X. Advances in targeting tumor microenvironment for immunotherapy. Front Immunol, 2024 Oct 3;15:1472772. [Google Scholar]
- Han Y, Tian X, Zhai J, Zhang Z. Clinical application of immunogenic cell death inducers in cancer immunotherapy: turning cold tumors hot. Front Cell Dev Biol, 2024 May 7;12:1363121. [Google Scholar]
- Mou J, Li C, Zheng Q, et al. Research progress in tumour angiogenesis and drug resistance in breast cancer. Cancer Biology and Medicine, 2024, 21(7): 571–585. [Google Scholar]
- Martin JD, Seano G, Jain RK. Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges. Annu Rev Physiol. 2019 Feb 10;81:505–534. [Google Scholar]
- Xiao M, Shi Y, Jiang S, Cao M, Chen W, Xu Y, Xu Z, Wang K. Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy[J]. Front Oncol. 2022 Nov 29;12:1039378. [Google Scholar]
- Liu Y, Si L, Jiang Y, et al. Design of pH-responsive nanomaterials based on the tumour microenvironment. Int J Nanomedicine, 2025, 20: 705–721. [Google Scholar]
- Liu B, Bian Y, Liang S, et al. One-Step Integration of Tumor Microenvironment-Responsive Calcium and Copper Peroxides Nanocomposite for Enhanced Chemodynamic/Ion-Interference Therapy. ACS Nano, 2022, 16(1): 617–630. [Google Scholar]
- Fang Z, Li X, Xu Z, et al. Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe₃O₄ nanoparticles for targeted drug delivery. International Journal of Nanomedicine, 2019, 14: 5785–5797. [Google Scholar]
- Li Q, Lai S, Shang H, et al. Construction and evaluation of biomass-modified mesoporous silica nanoparticles as enzyme-responsive and pH- responsive drug carriers for the controlled release of quercetin. Journal of Drug Delivery Science and Technology, 2024, 98: 105852. [Google Scholar]
- Feng L, Dong Z, Tao D, et al. The acidic tumor microenvironment: a target for smart cancer nano- theranostics. National Science Review, 2018, 5(2): 269–286. [Google Scholar]
- Chen Q, Feng L, Liu J, et al. Intelligent Albumin- MnO₂ Nanoparticles as pH-/H₂O₂-Responsive Dissociable Nanocarriers to Modulate Tumour Hypoxia for Effective Combination Therapy[J]. Adv Mater, 2016, 28(33): 7129–7136. [Google Scholar]
- Cui J, Zhang D, Qiao H, et al. MnO₂-coated nanodiamond-driven photodynamic therapy for enhanced antitumor effect by addressing hypoxia and glutathione depletion[J]. Particuology, 2024, 92: 305–315. [Google Scholar]
- Luo J, Cao J, Ma G, et al. Collagenase-Loaded H- TiO₂ Nanoparticles Enhance Ultrasound Imaging- Guided Sonodynamic Therapy in a Pancreatic Carcinoma Xenograft Model via the Digestion of Stromal Barriers. ACS Applied Materials & Interfaces, 2022, 14(36): 40535–40545. [Google Scholar]
- Zhang M, Xu C, Wen L, et al. A hyaluronidase- responsive nanoparticle-based drug delivery system for targeting colon cancer cells. Cancer Research, 2016, 76(24): 7208–7218. [Google Scholar]
- Xiao D, Zou J, Li Y, et al. A nanosystem targeting genomic instability and mitochondrial damage to stimulate STING pathway for synergistic immunotherapy for advanced prostate cancer. Biomaterials, 2026, 330: 124018. [Google Scholar]
- Meng X, Liu Z, Deng L, et al. Hydrogen Therapy Reverses Cancer-Associated Fibroblast Phenotypes and Remodels the Stromal Microenvironment to Stimulate Systemic Anti-Tumor Immunity. Advanced Science, 2024, 11(28): e2401269. [Google Scholar]
- Zanganeh S, Hutter G, Spitler R, et al. Iron oxide nanoparticles inhibit tumour growth by inducing pro- inflammatory macrophage polarization in tumour tissues. Nature Nanotechnology, 2016, 11(11): 986–994. [Google Scholar]
- Guo L, Zhang H, Liu P, et al. Preclinical Assessment of Paclitaxel- and Trastuzumab-Delivering Magnetic Nanoparticles Fe₃O₄ for Treatment and Imaging of HER2-Positive Breast Cancer[J]. Frontiers in Medicine, 2021, 8: 738775. [Google Scholar]
- Zhang Y, Ouyang Z, Zhan M, et al. An Intelligent Vascular Disrupting Dendritic Nanodevice Incorporating Copper Sulfide Nanoparticles for Immune Modulation-Mediated Combination Tumor Therapy. Small, 2023, 19(39): e2301914. [Google Scholar]
- Wang B, Hu S, Teng Y, et al. Current advances in nanotechnology for the diagnosis and treatment of malignant tumours. Signal Transduction and Targeted Therapy, 2024, 9(1): 200. [Google Scholar]
- Gandarias L, Faivre D. Clinical Translation of Inorganic Nanoparticles and Engineered Living Materials for Cancer Therapy. Chempluschem, 2024, 89(10): e202400090. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.